These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

900 related articles for article (PubMed ID: 21116949)

  • 1. Unique benefits of nanotechnology to drug delivery and diagnostics.
    McNeil SE
    Methods Mol Biol; 2011; 697():3-8. PubMed ID: 21116949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticles in medicine: therapeutic applications and developments.
    Zhang L; Gu FX; Chan JM; Wang AZ; Langer RS; Farokhzad OC
    Clin Pharmacol Ther; 2008 May; 83(5):761-9. PubMed ID: 17957183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticle therapeutics: a personal perspective.
    McNeil SE
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(3):264-71. PubMed ID: 20049796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chapter 8 - Nanoparticles: Transport across the olfactory epithelium and application to the assessment of brain function in health and disease.
    Aschner M
    Prog Brain Res; 2009; 180():141-52. PubMed ID: 20302833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanostructure-mediated drug delivery.
    Hughes GA
    Nanomedicine; 2005 Mar; 1(1):22-30. PubMed ID: 17292054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Micro- and nanoparticles--medical applications.
    Jătariu A; Peptu C; Popa M; Indrei A
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1160-9. PubMed ID: 20191893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inorganic hollow nanoparticles and nanotubes in nanomedicine Part 1. Drug/gene delivery applications.
    Son SJ; Bai X; Lee SB
    Drug Discov Today; 2007 Aug; 12(15-16):650-6. PubMed ID: 17706547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of nanotechnology in biomedicine.
    Navalakhe RM; Nandedkar TD
    Indian J Exp Biol; 2007 Feb; 45(2):160-5. PubMed ID: 17375555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A perspective of nanotechnology in hypersensitivity reactions including drug allergy.
    Montañez MI; Ruiz-Sanchez AJ; Perez-Inestrosa E
    Curr Opin Allergy Clin Immunol; 2010 Aug; 10(4):297-302. PubMed ID: 20485158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances and challenges of nanotechnology-based drug delivery systems.
    Jiang W; Kim BY; Rutka JT; Chan WC
    Expert Opin Drug Deliv; 2007 Nov; 4(6):621-33. PubMed ID: 17970665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifunctional nanoparticles--properties and prospects for their use in human medicine.
    Sanvicens N; Marco MP
    Trends Biotechnol; 2008 Aug; 26(8):425-33. PubMed ID: 18514941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PharmaMedDevice 2007. Issues in nanodrug delivery and personalized medicine.
    Bawa R
    IDrugs; 2007 Jul; 10(7):455-8. PubMed ID: 17642014
    [No Abstract]   [Full Text] [Related]  

  • 13. Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications.
    Fadeel B; Garcia-Bennett AE
    Adv Drug Deliv Rev; 2010 Mar; 62(3):362-74. PubMed ID: 19900497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-ordered nanopore and nanotube platforms for drug delivery applications.
    Losic D; Simovic S
    Expert Opin Drug Deliv; 2009 Dec; 6(12):1363-81. PubMed ID: 19860534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticles and the blood coagulation system. Part I: benefits of nanotechnology.
    Ilinskaya AN; Dobrovolskaia MA
    Nanomedicine (Lond); 2013 May; 8(5):773-84. PubMed ID: 23656264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters.
    Gaumet M; Vargas A; Gurny R; Delie F
    Eur J Pharm Biopharm; 2008 May; 69(1):1-9. PubMed ID: 17826969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The growing role of nanotechnology in combating infectious disease.
    Blecher K; Nasir A; Friedman A
    Virulence; 2011; 2(5):395-401. PubMed ID: 21921677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanotechnology and glaucoma: a review of the potential implications of glaucoma nanomedicine.
    Kim NJ; Harris A; Gerber A; Tobe LA; Amireskandari A; Huck A; Siesky B
    Br J Ophthalmol; 2014 Apr; 98(4):427-31. PubMed ID: 24246373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Has nanotechnology led to improved therapeutic outcomes?
    Bosselmann S; Williams RO
    Drug Dev Ind Pharm; 2012 Feb; 38(2):158-70. PubMed ID: 22191583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nanotechnology applications in pharmacology].
    Seĭfulla RD; Timofeev AB; Ordzhonikidze ZG; Rozhkova EA; Kulikova EV; Druzhinin AE; Kuznetsov IuM; Kim EK
    Eksp Klin Farmakol; 2008; 71(1):61-9. PubMed ID: 18365491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.